Sbi Securities Co., Ltd. Lantern Pharma Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 2,108 shares of LTRN stock, worth $10,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,108Holding current value
$10,540% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LTRN
# of Institutions
33Shares Held
1.28MCall Options Held
39.8KPut Options Held
6.1K-
Vanguard Group Inc Valley Forge, PA364KShares$1.82 Million0.0% of portfolio
-
Cm Management, LLC185KShares$925,0000.57% of portfolio
-
New Edge Advisors, LLC New Orleans, LA137KShares$686,6900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$437,1750.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny84KShares$420,0000.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $54.2M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...